Founders Financial Alliance, LLC Nymox Pharmaceutical Corp Transaction History

Founders Financial Alliance, LLC

  • $352 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 04, 2021
SELL
$1.84 - $2.83 $920 - $1,415
-500 Closed
0 $0
Q3 2020

Nov 13, 2020
BUY
$2.3 - $3.66 $1,150 - $1,830
500 New
500 $1,000

Others Institutions Holding NYMX

# of Institutions
6
Shares Held
150K
Call Options Held
0
Put Options Held
0
View Full List

About NYMOX PHARMACEUTICAL CORP

NYMX Quotes by TradingView
  • Ticker NYMX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 91,265,000
  • Market Cap $42.9M
  • Description
  • Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which has completed Phase III clinical trials for the treatment of benign prostatic hyperpl...
More about NYMX
Track This Portfolio

Track Founders Financial Alliance, LLC Portfolio

Follow Founders Financial Alliance, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Founders Financial Alliance, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Founders Financial Alliance, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email